Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study.

Jorge R Georgakopoulos Dropen Sheka Brian Rankin Khalad Maliyar Alexander Rimke Vimal H Prajapati Jensen Yeung

J Am Acad Dermatol

Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address:

Published: December 2023

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jaad.2023.08.059	DOI Listing

Publication Analysis

Top Keywords

real-world effectiveness

effectiveness safety

safety upadacitinib

upadacitinib treatment

treatment atopic

atopic dermatitis

dermatitis adult

adult patients

patients switched

switched dupilumab

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!